|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 15721694.6 (espacenet) (Federated) (European Patent Register), 20150507 | | Patent/reg. no. and date | DK/EP 3140318, 20191030 | | Publication date | 20170315 | | Priority no. and date | GB 201408135, 20140508 | | EP pub. no. and date |
EP 3140318 20170315 | | Effective date | | | Applicant/owner | selectION Therapeutics GmbH, Am Klopferspitz 19
82152 Martinsried, DE | | Applicant ref. no. | P70569DK01 | | Inventor | KLOSTERMANN, Andreas, c/o Conogenetix Biosciences GmbH
Am Klopferspitz 19
82152 Martinsried, DE,
STOCKHAUS, Jörg, c/o Conogenetix Biosciences GmbH
Am Klopferspitz 19
82152 Martinsried, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07K 14/47 (2006.01) | | Title | KV1.3-KALIUMKANALANTAGONISTER | | Int. application no. | EP2015060073 | | Int. publication no. | WO2015169901 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
